No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
The Inhaled Particle market is composed of a variety of products used to deliver medication to the lungs. Inhalers and nebulisers are two of the most common devices used to deliver medication in this way. Inhalers are handheld devices that deliver medication in the form of a mist or aerosol. Nebulisers are larger devices that use compressed air to turn liquid medication into a mist that can be inhaled. Both devices are used to treat a variety of respiratory conditions, such as asthma, COPD, and cystic fibrosis.
Inhaled particle products are used in both the home and hospital settings. They are often used in combination with other treatments, such as oral medications and lifestyle changes. The market is highly competitive, with a variety of companies offering products in this space. Some of the major players in the market include GlaxoSmithKline, Boehringer Ingelheim, Novartis, and AstraZeneca. Show Less Read more
